The FDA took more than 30 years to update a standard for what foods could be labeled as healthy, despite calls for faster oversight of rapidly shifting labeling trends from members of Congress, doctors, and consumer advocates
Ive really only mentioned the biggest con of GLP-1 agonists which is a potential risk of thyroid cancer but there are others to consider such as muscle loss as well
Despite the absence of functional MC4R signalling, all three treatments produced substantial anti-obesity effects
Optimize GLP-1 Results with bistroMD Chef-prepared, gourmet meals designed to make your GLP-1 lifestyle easyand incredibly effective
But GLP-1 is also produced in the central nervous system, predominantly in the brainstem, and its receptors are expressed in multiple regions of the brain, including the striatum and nucleus accumbens
Healthcare regulators, including the UKs MHRA and NICE, have carefully reviewed the evidence and continue to endorse GLP-1 receptor agonists, provided patients and prescribers remain aware of the very small potential risk and take appropriate precautions